The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience

Table 4 Bivariate Analysis Association between SIBO and Significant Steatosis

Variables	Significant Steatosis		Total (%)	p value	PR	CI 95%
Variables	Yes	No	Total (%)	p value	PR	CI 95%
SIBO, n (%)
Yes	23 (63.9)	13 (36.1)	36 (100)	0.951	1.026	0.452–2.329
No	50 (63.3)	29 (36.7)	79 (100)

SIBO Small Intestinal Bacterial Overgrowth, PR Prevalence Ratio, CI Confidence Interval

ISSN: 1471-230X